Clinical Trials Directory

Trials / Completed

CompletedNCT06900569

Ashwagandha Supplementation for Prevention of Muscle Damage

Ashwagandha Supplementation for Recovery From Muscle-damaging Exercise and Sleep Quality

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
19 (actual)
Sponsor
University of Saskatchewan · Academic / Other
Sex
All
Age
18 Years – 35 Years
Healthy volunteers
Accepted

Summary

Ashwagandha is an herbal supplement that has a wide range of benefits related to exercise when supplemented for about 8-12 weeks. This study aims to investigate whether short-term Ashwagandha supplementation can enhance muscle recovery following exercise by measuring muscle strength recovery, swelling, and soreness in the biceps.

Detailed description

The purpose of the study is to determine the effects of Ashwagandha supplementation on recovery from muscle-damaging exercise. Ten to twenty participants will be randomized to receive Ashwagandha supplementation (600 mg/d) or placebo for 10 days. On day 7, participants will perform a muscle damaging exercise session (six sets of concentric and emphasized eccentric repetitions with the biceps). Before and after exercise and at 24, 48, and 72 hours after exercise, isometric muscle strength, muscle swelling (ultrasound), and muscle soreness will be assessed. The investigators hypothesize the Ashwagandha will alleviate symptoms of muscle damage (swelling and soreness) and enhance strength recovery after a bout of muscle-damaging exercise.

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENTAshwagandha600 mg/d Ashwagandha
DIETARY_SUPPLEMENTPlacebo600 mg/d placebo

Timeline

Start date
2025-03-22
Primary completion
2025-04-30
Completion
2025-05-15
First posted
2025-03-28
Last updated
2026-02-23

Locations

1 site across 1 country: Canada

Source: ClinicalTrials.gov record NCT06900569. Inclusion in this directory is not an endorsement.